About Agios Pharmaceuticals
We are focused on raising awareness for rare hemolytic anemias, including pyruvate kinase deficiency, thalassemia and sickle cell disease. Throughout February, we are working to raise donations for the Sickle Cell Community Consortium’s COVID-19 Relief Fund to ensure families impacted by sickle cell disease have the educational resources (devices, online tools, tutors, etc.) that they need to succeed in a remote learning environment. In addition, we are hosting a Facebook Live event focused on pyruvate kinase deficiency. We are also holding an internal speaker series that includes presentations about health equity in sickle cell disease, and the experiences of sickle cell disease and thalassemia patients. Finally, we are sponsoring the Rare Disease Day event organized by our local industry organization, MassBio, which is focused on strategies to better address health inequity and racial disparities among the rare disease community.